PYPD · PolyPid Ltd. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-15 | Barenholz Yechezkel |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Stock option (right to buy)
|
9,132 |
| 2026-07-15 | Akselbrad Dikla Czaczkes |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning May 11, 2026 until May 11, 2030. |
Stock option (right to buy)
|
149,000 |
| 2026-07-15 | Krinsky Itzhak |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Stock option (right to buy)
|
9,132 |
| 2026-07-15 | Stein Robert Benjamin |
President, Regenerative Med. |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Stock option (right to buy)
|
9,132 |
| 2026-07-15 | BenAmram Joseph |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Stock option (right to buy)
|
9,132 |
| 2026-07-15 | Dror-Darwish Nir |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Stock option (right to buy)
|
9,132 |
| 2026-07-15 | Story Brooke |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Stock option (right to buy)
|
9,132 |
| 2026-05-11 | Warshavsky Ori |
Chief Operating Officer - US |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning May 11, 2026 until May 11, 2030. |
Stock option (right to buy)
|
46,000 |
| 2026-05-11 | Missulawin Jonathan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning May 11, 2026 until May 11, 2030. |
Stock option (right to buy)
|
49,000 |
| 2026-05-11 | Hazan Dalit Fellous |
Deputy CEO, EVP, RD, CRA |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The options vest on a quarterly basis beginning May 11, 2026 until May 11, 2030. |
Stock option (right to buy)
|
75,000 |